Methamphetamine-induced rapid decrease in dopamine transporter function: Role of dopamine and hyperthermia

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 1077-1085

  Metzger, Ryan R ^b   Haughey, Heather M ^a   Wilkins, Diana G ^a   Gibb, James W ^a,b   Hanson, Glen R ^a,b   Fleckenstein, Annette E ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; ETICLOPRIDE; METHAMPHETAMINE; METIROSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HYPERTHERMIA; LIMBIC SYSTEM; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

ANIMALS; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEVER; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN;

EID: 0033681325     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Effects of repeated administration of a high dose of methamphetaminhe on dopamine and glutamate release in rat striatum and nucleus accumbens
2. Modification of dopamine transporter function: Effect of reactive oxygen species and dopamine
3. Physiological and anatomical evidence for colocalization of neostriatal D1 and D2 dopamine receptors
4. Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites
5. Role of dopamine autexidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP induced parkinsonism
6. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress
7. Oxygen radicals diminish dopamine transporter function in rat striatum
8. Rapid and reversible effects of methamphetamine on dopamine transporters
9. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration
10. Protein kinase C and dopamine transport. 1. Effects of amphetamine in vivo
11. Protein kinase C and dopamine transport. 2. Effects of amphetamine in vitro
12. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine
13. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
14. Differential regional effects of methamphetamine on the activities of tryptophan and tyrosine hydroxylase
15. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain
16. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra
17. Increased in vivo phosphorylation of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine
18. Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes
19. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter
20. Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: Evidence for involvement of pharmacologically distinct NMDA receptors?
21. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters
22. Hippocampus norepinephrine, caudate dopamine and serotenin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
23. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine
24. Protein measurement with the Folin phenol reagent
25. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations
26. Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal
27. Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum
28. Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine
29. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: Attenuation by dopamine D1 or D2 entagonists
30. Excitotoxic striatal lesions protect against subsequent methamphetamine-induced dopamine depletions
31. Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
32. Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: Effects of citalopram and chlorimipramine
33. Repeated binge exposures to amphetamine and methamphetamine: Behavioral and neurochemical characterization
34. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons
35. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes
36. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine
37. Role of dopamine D1- and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens
38. Analysis of phenylpropanalamine by positive chemical ionization mass spectrometry
39. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro
40. Oxidation of 5-hydroxytryptamine and 5,7-dihydroxytryptamine. A new oxidation pathway and formation of a novel neurotoxin
41. The effects of methamphetamine on the production of free radicals and oxidative stress
42. Oxidation chemistry of dopamine: Possible insights into the age-dependent loss of dopaminergic nigrostriatal neurons
43. Regulation of the functional activity of the human dopamine transporter by protein kinase C
44. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes